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ABSTRACT
Introduction Resilience in healthcare (RiH) is understood 
as the capacity of the healthcare system to adapt to 
challenges and changes at different system levels, to 
maintain high- quality care. Adaptive capacity is founded in 
the knowledge, skills and experiences of the people in the 
system, including patients, family or next of kin, healthcare 
providers, managers and regulators. In order to learn 
from and support useful adaptations, research is needed 
to better understand adaptive capacity and the nature 
and context of adaptations. This includes research on the 
actors involved in creating resilient healthcare, and how 
and in what circumstances different groups of patients and 
other key healthcare stakeholders enact adaptations that 
contribute to resilience across all levels of the healthcare 
system.
Methods and analysis This 5- year study applies an 
interactive design in a two- phased approach to explore 
and conceptualise patient and stakeholder involvement 
in resilient healthcare. Study phase 1 is exploratory 
and will use such data collection methods as literature 
review, document analysis, interviews and focus groups. 
Study phase 2 will use a participatory design approach to 
develop, test and evaluate a conceptual model for patient 
and stakeholder involvement in RiH. The study will involve 
patients and other key stakeholders as active participants 
throughout the research process.
Ethics and dissemination The RiH research programme 
of which this study is a part is approved by the Norwegian 
Centre for Research Data (No. 864334). Findings will be 
disseminated through scientific articles, presentations 
at national and international conferences, through social 
media and popular press, and by direct engagement 
with the public, including patient and stakeholder 
representatives.
INTRODUCTION
Resilience in healthcare (RiH) is funda-
mental to understanding quality in health-
care provision1 and is defined by Wiig and 
colleagues as ‘the capacity to adapt to chal-
lenges and changes at different system 
levels, to maintain high- quality care’.2 As 
an emerging field of study within health 
services research, RiH views healthcare as a 
complex adaptive system. Complex adap-
tive systems are fundamentally characterised 
by uncertainty and changing conditions, 
with multiple individual yet interconnected 
stakeholders acting in both predictable and 
unpredictable ways.3 In response to inherent 
uncertainties and highly dynamic conditions, 
people in complex healthcare systems create 
and uphold quality and safety by developing 
and enacting adaptive capacities. This allows 
them to anticipate and respond to emerging 
changes, challenges, variations or disruptions 
to keep the system functioning.2 4–7
The concept of adaptation in complex 
systems has a variety of interpretations.6 Adap-
tive capacity as a key feature of RiH may be 
understood as a dynamic set of internal (ie, 
cognitive and behavioural) and external (eg, 
colleagues, networks, regulation) resources 
used by individuals and teams within an 
organisational context to adapt everyday 
functioning according to changing condi-
tions.1 8 As such, adaptive capacity is founded 
in the knowledge, skills and experiences of 
the people in the system, and includes system- 
wide performance adjustments, workarounds, 
Strengths and limitations of this study
 ► This study will contribute to a limited yet growing 
body of knowledge of patient and stakeholder in-
volvement (PSI) in resilience in healthcare (RiH).
 ► This study will translate system- wide concepts of 
resilience into practice by developing and testing a 
conceptual model for PSI in RiH.
 ► This study adopts a participatory approach to the 
development and test of a conceptual model for 
PSI in RiH, involving stakeholders from a variety of 
healthcare contexts across all levels of the health-
care system.
 ► This study features a broad approach to healthcare 
stakeholders which include patients and family car-
ers, as well as providers, managers and regulators 
of healthcare services.
 ► The 5- year project period may restrict opportunities 
for documenting long- term outcomes of the imple-
mentation of the conceptual model for PSI in RiH.
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trade- offs, sense- making efforts and improvisations.6–9 In 
order to improve healthcare quality, it is imperative to 
learn from and support useful adaptations.10 11 Research 
is therefore needed to better understand adaptive 
capacity and the nature and context of adaptations—not 
least the actors involved in creating resilient healthcare. 
This includes research on how and in what circumstances 
different groups of patients and other key healthcare 
stakeholders enact adaptations that contribute to resil-
ience. Research is also needed that explores how patient 
and stakeholder involvement (PSI) in resilient healthcare 
can be developed and supported across all levels of the 
healthcare system. This study seeks to address these gaps 
in the research knowledge.
PSI in resilient healthcare
User involvement is a key dimension of healthcare quality 
that is considered crucial to understand and operation-
alise RiH.2 The notion of user involvement here is one 
that emphasises the value and importance of including 
the knowledge and experiences of a diversity of stake-
holders in efforts to understand and improve healthcare 
services.12 A healthcare stakeholder is any person, group 
or organisation who provides, receives, manages, regu-
lates or pays for healthcare, and can include, for example, 
patients, family or next of kin, healthcare professionals, 
managers, regulatory bodies, non- governmental organ-
isations, municipalities and regional authorities.1 Tradi-
tionally there has been little empirical research focused 
on contributions to resilient healthcare from patients 
and stakeholders such as family carers.9 13 It is increas-
ingly acknowledged, however, that patients and other 
key stakeholders are important co- creators of RiH, and 
that without knowledge of how they both facilitate and 
disrupt RiH, our understanding of everyday clinical work 
and how best to improve healthcare quality will remain 
limited.14–16
Emerging research indicates that adaptation and 
responsiveness to variation or changes in complex 
healthcare systems require the involvement of patients 
and stakeholders across all levels of the healthcare 
system.14 15 17–19 Studies have, for example, found that 
next of kin in cancer care contribute to system resilience 
and healthcare quality by brokering knowledge between 
patients and clinicians; bridging gaps between care levels 
as well as provider organisations; filling gaps on the ward; 
and otherwise performing tasks that scaffold or support 
the work of clinicians.20 21 Similarly, a study of next of kin 
involvement in regulatory activities found that the infor-
mation provided by next of kin gives a fuller picture of 
the cases under investigation and that this type of involve-
ment can lead to more comprehensive and robust regu-
latory findings.22 23 Further multistakeholder perspectives 
are vital to gain more complete knowledge of how to 
create, sustain and support resilient healthcare.9 14 More 
research is also needed on the way PSI in RiH takes place 
and how to facilitate and support involvement, to improve 
healthcare quality.
The RiH research programme
The study on PSI in resilient healthcare described here 
is part of a comprehensive research programme called 
RiH.1 The objective of the overall RiH programme is 
to reform the understanding of quality in healthcare 
by developing and testing a theoretical and practical 
RiH framework. The RiH research programme will be 
conducted over a 5- year period (2018–2023) and consists 
of five inter- related work packages, including one focused 
on the role of collaborative learning in RiH24 and one 
which concerns an international comparative study of 
RiH and teamwork.25 This study protocol is limited to the 
work package concerned with the study of PSI in RiH.
AIM AND RESEARCH OBJECTIVES
The main aim of this study is to describe how patients 
and other key stakeholders are involved in creating and 
sustaining RiH and how these practices can be supported 
and enhanced to facilitate high- quality healthcare. The 
study’s primary research question is: ‘How can involve-
ment of patients and stakeholders in RiH be described 
and improved?’ Specifically, the research objectives of 
this study are as follows:
1. To explore how patients and stakeholders contribute 
to RiH.
2. To develop a conceptual model for how PSI in RiH can 
be understood and improved.
3. To test and refine the conceptual model of PSI in RiH 
across differing empirical contexts using collaborative 
learning tools and innovations.
To address these objectives, the following research 
questions will be investigated:
 ► Which healthcare stakeholders are involved in the 
creation of RiH in different contexts?
 ► How and in which contexts do different groups of 
patients and stakeholders contribute to RiH across 
different levels of the healthcare system?
 ► What are the key features of a conceptual model for 
PSI in RiH, and how can it be tested and validated?
 ► What are central outcomes of the evaluation of the 
conceptual model for PSI in RiH?
METHODS AND ANALYSIS
Design
This study on PSI in resilient healthcare has an inter-
active design.26 Interactive research is a participa-
tory approach concerned with developing theoretical 
knowledge of practical relevance. It is characterised by 
continuous collaboration and joint learning between 
the researchers, stakeholders and participants. As such, 
this study will involve patients, carers, healthcare profes-
sionals, regulatory bodies, the public and other major 
stakeholders (eg, patient organisations, policymakers) 
as partners throughout the research process, including 
as co- researchers. The study will be conducted in two 
phases. Study phase 1 is exploratory and will feature a 
variety of data collection methods, including literature 
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review, meta- synthesis of results from selected empirical 
studies, interviews and focus groups. Study phase 2 will 
use a participatory approach to develop, implement and 
evaluate a conceptual model for PSI in RiH, using focus 
group and observational data to study impact. See figure 1 
for a visual presentation of the study phases.
Study phase 1: exploring patient and stakeholder 
contributions to RiH
The purpose of phase 1 is to explore how patients and 
stakeholders contribute to RiH and to establish the 
current knowledge base on PSI in RiH. This will be done 
by way of a multifaceted approach featuring a scoping 
review of the literature, an explorative meta- synthesis of 
findings from a sample of selected empirical projects and 
a stakeholder analysis.
Scoping reviews are recommended when the purpose 
of the review is to explore the breadth or depth of the 
literature on a topic; map and summarise evidence; 
clarify concepts; identify or address knowledge gaps; and 
inform future research.27 28 The scoping review will focus 
on patient and family and other caregivers’ contributions 
to RiH and will seek to answer the question ‘How and in 
which contexts do different groups of patients, families 
and caregivers contribute to resilience across different 
levels of the healthcare system?’ The scoping review will 
be conducted according to an established methodolog-
ical approach.29 The chosen search strategy will aim to 
identify academic output (ie, peer- reviewed journal 
articles, book chapters, books, conference proceed-
ings), using the following databases: Medline, SCOPUS, 
ScienceDirect and CINAHL. The search terms to be used 
are presented in box 1.
The inclusion criteria are that research items must 
report on empirical studies with qualitative or mixed- 
methods designs that describe adaptations, adaptive 
capacity or organisational resilience in healthcare settings. 
Furthermore, studies from settings at all levels (micro, 
meso and macro) of the healthcare system are of interest, 
and studies must feature patients, families, and/or care-
givers as participants. Conversely, research items not from 
the healthcare setting; without patients, families, or care-
givers as participants; and those describing individual or 
psychological resilience will be excluded. Included items 
will be restricted to those published in English only. No 
limits will be set on publication dates. In addition to the 
electronic searches, we will undertake reference tracking 
and citation tracking alongside hand searches of key 
items. The data extraction process will focus on purpose 
and aim of the studies; study design; participant types 
and characteristics; type of healthcare service and setting 
described; the characteristics of identified performance 
variation or adaptations and the actors involved; and the 
empirical context of the performance variation or adap-
tations identified. The results of the scoping review will 
be reported in line with the Preferred Reporting Items 
for Systematic Reviews and Meta- Analyses Extension for 
Scoping Reviews reporting checklist.30
For the meta- synthesis, publicly available docu-
ments and publications from a broad sample of empir-
ical research projects will be selected according to a 
set screening protocol, which includes the use of a 
Quality and Resilience Trigger Tool. The details on this 
screening protocol and the trigger tool have already been 
Figure 1 Study phases.
Box 1 Search terms for the scoping review
resilien* OR safety*II OR adaptive*capacity OR adapt* OR varia* OR 
monitor* OR adjust* OR anticipat* OR respon* OR detect* OR learn*
AND
patient* OR (carer* or caregiver* or informal carer* or family mem-
ber* or relative* or next- of- kin)
AND
healthcare OR health care
*=wildcard filter.
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published as part of the overall RiH research programme 
protocol.1 Specifically, the sample will be drawn from a 
pool of approximately 50 research projects, including 
post- doctoral projects and PhD projects, which involve 
researchers from the SHARE–Centre for Resilience in 
Healthcare and were conducted in Norway between 2010 
and 2021 (some are ongoing). The screening process will 
establish if and how the projects relate to resilience and 
which healthcare quality components they cover. After 
screening, a total sample of around 20 empirical proj-
ects will be selected to reflect a comprehensive range of 
healthcare settings, stakeholders, quality dimensions (ie, 
patient safety, continuity of care, patient- centeredness, 
clinical effectiveness), and adaptive capacities at indi-
vidual, team/unit, organisational, and larger system level.
The stakeholder analysis31 will be undertaken in a 
selected sample of empirical healthcare studies with the 
aim of mapping relevant actors in the sample by identi-
fying who they are and exploring their roles, interests, 
needs and inter- relations, where in the system they are 
involved, how and in which contexts they are involved in 
RiH, and what type of adaptive capacities they are involved 
in. We will also explore the influences and resources they 
may exert on performance variability and how adapta-
tions are enacted to facilitate RiH in certain contexts. 
The knowledge generated in the stakeholder analysis 
will be used to identify stakeholders suitable for involve-
ment in the design and development of the conceptual 
model, and also to better understand the context in 
which the model will be tested and implemented.32 Aside 
from helping to inform appropriate planning and devel-
opment processes, conducting a stakeholder analysis 
is useful as part of building a collaborative approach to 
the development and delivery of healthcare services and 
healthcare innovations.33
Participants
This phase of the study will draw participants from a 
total sample of 30–40 researchers involved in completed, 
ongoing, or newly initiated empirical research projects 
with a theoretical and/or empirical connection to PSI 
and/or RiH. As noted above, the sampling process will 
be project focused and entail a screening process based 
on publicly available information about relevant proj-
ects. This will establish how the projects relate to resil-
ience and which healthcare quality components they 
encompass.1 Once the sample of projects has been estab-
lished, the researchers involved in the included projects 
will be approached and recruited to participate in the 
study using one or more of the data collection methods 
described below.
Data collection
The data collection process during this part of the study 
will, as noted above, feature meta- synthesis of findings 
from existing empirical projects, using publicly available 
material such as peer- reviewed articles, book chapters, 
PhD theses and project reports. The meta- synthesis will 
focus on findings related to the links between PSI and 
RiH. Data collection in the stakeholder analysis will entail 
individual interviews with 10–15 researchers concerning 
findings, activities and experiences related to PSI and RiH, 
in either the planning and/or execution of their research 
projects, as well as focus group interviews with researchers 
(approximately three to four interviews with five to seven 
participants) to brainstorm and categorise stakeholders 
and their roles, interests, inter- relations and influence.34 
A range of topics related to involvement in RiH will be 
explored during these interviews, including who, how 
and in which situations patients and stakeholders are 
involved in and contribute to resilient healthcare; types 
of involvement; drivers and barriers to involvement; 
and contextual factors surrounding patients’ and other 
stakeholders’ contributions to RiH. Finally, data collec-
tion during this study phase will include observations of 
different types of activities in ongoing projects, such as 
workshops, stakeholder meetings, co- creation activities, 
etc to better understand links between PSI and various 
aspects of RiH through practical examples.
Data analysis
The data analysis in the meta- synthesis will combine 
both a thematic inductive approach and a deductive 
approach based on four key questions deemed central to 
understand and operationalise RiH in both research and 
practice.2 These four questions are resilience for what, to 
what, of what and through what. This combining of induc-
tive and deductive approaches is to ensure identifica-
tion of key elements of both involvement and adaptive 
capacity central to RiH. For the meta- synthesis of empir-
ical research projects, data will be analysed according to 
the following steps, to ensure a sound analytical process 
across different study designs and empirical settings:
1. Development of short narratives. A narrative of three 
to four pages will be written for each study included 
in the meta- analysis. The narrative content will focus 
on answering the four resilience questions: resilience for 
what, to what, of what and through what? The narratives 
will also identify study settings, levels, context, stake-
holders, contributions and adaptations.
2. Analysis of the resilience narratives according to an in-
ductive thematic synthesising approach. All narratives 
that are generated in step 1 will be subject to an induc-
tive thematic synthesis to identify the key stakeholders 
involved in creating and supporting adaptive capacity 
at different system levels, and to establish knowledge of 
the ways different groups of patients and stakeholders 
contribute to adaptations across various healthcare set-
tings, including important contextual conditions for 
supporting and enhancing their involvement in resil-
ient healthcare.
Qualitative data from interviews, focus groups and 
observations will be analysed using a combined thematic 
inductive approach and a deductive approach according 
to the same four key questions mentioned above. The 
totality of the data material collected in phase 1, including 
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the outcomes of the scoping review, the meta- synthesis 
and the qualitative data in the stakeholder analysis, will 
be combined to provide a foundation for developing the 
conceptual model for PSI in RiH. A procedure of joint 
display of data35 will guide the process of combining 
diverse data sources during this analysis.
Study phase 2: develop, test and evaluate a conceptual model 
for PSI in RiH
The purpose of phase 2 is to develop a conceptual model 
for how PSI in RiH can be understood and improved, 
and to test and evaluate the model using collaborative 
learning tools and innovations. Findings from phase 1 will 
feed into phase 2, where the study will apply experience- 
based co- design36 principles in a two- part participatory 
process (A and B) to develop the conceptual model based 
on a synthesising of the prior findings on how patients 
and stakeholders contribute to adaptive capacity, and 
how the drivers for their involvement can be understood. 
Following their identification as part of the stakeholder 
analysis in study phase 1, key actors will be involved in 
the process to develop the model. The conceptual model 
will then be tested and validated through a set of learning 
components (eg, structured meeting arenas, simulation 
scenarios, interactive digital guides, webinars, etc) in close 
collaboration with the work package focused on devel-
oping knowledge of the role of collaborative learning in 
RiH.24 Patients and other stakeholders will be involved as 
co- researchers in the entire process.
The development of the conceptual model for PSI in 
RiH will entail a two- part participatory design process,36 
which will involve a broad group of stakeholder represen-
tatives (eg, patients, next of kin, healthcare professionals, 
managers, policymakers, regulators) and where the main 
aim is to operationalise the findings from study phase 1. 
In the first part of this process (A), principles for PSI in 
RiH will be established through a consensus process. This 
will include principles for how to support and strengthen 
stakeholder involvement to facilitate adaptive capacity at 
the individual, team and intraorganisational level. The 
second part of the participatory design process (B) will 
then aim to develop prototype simulation scenarios using 
the PSI principles established during process A, at each 
level of the healthcare system (ie, micro, meso, macro). 
The prototype scenarios will be pilot tested in simulation 
centres at the University of Stavanger and the Norwegian 
University of Science and Technology in Gjøvik, both of 
which are partners in the RiH research programme.
Based on the results from the pilot testing, the scenarios 
will be further refined and will constitute the basis for 
further implementation and evaluation of the conceptual 
model in three empirical settings representing different 
clinical, managerial and regulatory areas across all levels 
of the Norwegian healthcare system. The first setting 
will have a focus on patient and stakeholder contribu-
tions to individual and team- based adaptive capacities at 
the micro- level. The second setting will focus on patient 
and stakeholder contributions to organisational adaptive 
capacities at the meso- level. The third setting will focus 
on patient and stakeholder contributions to intraorgan-
isational adaptive capacities at the macro- level. A RiH 
laboratory will be established to assist these implemen-
tation activities. The RiH laboratory will combine digital 
learning formats, such as internet- based resources, virtual 
simulation scenarios, podcasts, etc with testing at the 
noted simulation centres as well as in situ simulation in 
clinical settings. The implementation and evaluation of 
the conceptual model for PSI in RiH will take place over 
a 12- month period. Both positive and negative impacts 
of the conceptual model will be appraised using a partic-
ipant observation approach as part of a process evalua-
tion.37 38
Participants
The consensus process in participatory design process 
A will involve 15–20 stakeholder representatives from 
various settings across different levels of the healthcare 
system. These participants will be selected in accor-
dance with the findings from the stakeholder analysis in 
study phase 1, but will likely include patients, family or 
next of kin, healthcare professionals, managers, policy-
makers and regulators. For participatory design process 
B, approximately 15–20 participants will be recruited, 
including clinical experts, education experts and repre-
sentatives from different levels of the healthcare system, 
as well as patients and family or next of kin representa-
tives from different clinical settings like hospitals, home 
healthcare services, nursing homes, general practice and 
prehospital services.
Participants in the subsequent implementation and 
evaluation process will be recruited from the three 
different empirical settings in Norway where the concep-
tual model for PSI in RiH is to be tested. The participants 
in this part of the study will thus include end users from 
these three, yet- to- be determined healthcare settings, 
representing all three levels of the healthcare system (eg, 
patients and healthcare professionals at the micro- level, 
managers at the meso- level and regulators at the macro- 
level). Around 25–30 participants will be involved in 
testing and evaluating the conceptual model at each of 
the three separate empirical settings, meaning that a total 
of approximately 70–90 participants will be part of the 
testing of the conceptual model.
Data collection
For the first participatory design process (A), the data 
collection will be focused around the consensus process to 
establish principles for PSI in RiH. During this consensus 
process, the research team will conduct consensus meet-
ings, workshops and focus group interviews with key 
stakeholders. Around four to seven meetings and work-
shops and four to seven focus group interviews, each with 
four to eight participants, will be undertaken. Themes 
for the workshops and meetings will be set based on the 
findings from phase 1, though with a likely focus on, for 
example, who the patients and stakeholders are, how they 
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contribute to adaptive capacity and in which contexts, 
and how to strengthen their involvement in useful 
adaptations.
As part of the second participatory design process (B), 
which as noted is concerned with developing prototype 
simulation scenarios based on the conceptual model’s 
principles of PSI, scenarios will be tested and refined in 
the involved simulation centres using an iterative process. 
During this process, data will be collected through obser-
vations and focus group interviews with different partic-
ipants as described above. We estimate approximately 
20 hours of observations and four to six focus group 
interviews with five to seven participants in each will be 
conducted to refine the prototype scenarios.
Data collection during the subsequent implementa-
tion and evaluation of the principles of the PSI concep-
tual model in empirical practice will include observation, 
focus group interviews and individual interviews. Data 
will be collected at three separate stages of the imple-
mentation process: prior to implementation, halfway 
through and at the end of the implementation period. 
Around 10–15 interviews and 2–3 focus groups with 5–7 
participants each are envisaged before, during and after 
implementation for each of the three empirical settings 
involved. In addition, we will conduct observations of the 
implementation process itself to understand the impact 
of PSI in the collaborative learning activities. The main 
purpose of the interviews and observation is to under-
stand how the model for PSI in RiH functions in different 
empirical settings.
Data analysis
The process evaluation will integrate findings from the 
interviews, focus group interviews and observation. The 
procedure of joint display of data30 will be applied to iden-
tify how patients and stakeholders contribute to adaptive 
capacity, and how to support their involvement in RiH 
to enable adaptive capacity at the individual, team and 
intraorganisational level.
Patient and public involvement
Patient and public involvement representatives were 
involved in the development of the original funding 
proposal for the RiH research programme.1 The RiH 
research programme has a patient and citizen repre-
sentative as co- chair of its international Expert Advisory 
Board, who has been involved in the overall project 
development and has contributed to key aspects of its 
design. This patient and citizen representative is also a 
coauthor (author CC) on this paper and has contributed 
to the design of this dedicated PSI work package. This 
work package aims to systematically involve patients and 
other key stakeholders from the Norwegian healthcare 
system in the overall research programme in multiple 
ways, for example, as representatives on PSI panels, 
which will be consulted throughout the conduct of this 
study, and as study participants and co- researchers in a 
collaborative, interactive research process. Patients and 
other stakeholders will also be involved in publications, 
as well as public engagement activities and in translating 
research into practice.
Limitations
There are some potential limitations to this study. First, it 
must be noted that the outcomes of the empirical imple-
mentation and evaluation of the conceptual model of PSI 
in resilient healthcare may have limited transferability 
beyond the particular empirical healthcare settings in 
which the principles of the conceptual model are to be 
tested. Second, the lack of involvement of patient stake-
holders from the Norwegian context at the planning and 
design stage of the studies featured in the overarching 
RiH research programme can be considered a limita-
tion. However, the decision to apply an international 
perspective at the design stage was made to ensure that 
the PSI work package commits to extensive engagement 
of patients and stakeholders that meets international 
expectations for exemplary participation in all facets 
of the research. As noted above, this is a work package 
dedicated to PSI, which will see Norwegian stakeholders 
including patient and family representatives be involved 
throughout the remainder of the research process.
ETHICS AND DISSEMINATION
Ethics
The overall RiH research programme, of which this 
study is a part, is approved by the Norwegian Centre for 
Research Data (NSD) (reference number: 864334). As 
per NSD requirements, a formal ‘notification of changes’ 
will be submitted on completion of study phase 1, when 
further details on the data collection (populations, 
settings, sampling, etc) in study phase 2 have been estab-
lished. NSD will then assess the reported changes to estab-
lish if they have any consequences for the ethics approval 
already granted, for example, in relation to the handling 
and processing of data to be collected in phase 2.
Dissemination
This study on PSI in resilient healthcare is part of the 
RiH research programme, which has a publication and 
dissemination strategy focused on the sharing of scien-
tific knowledge, information and results, and on public 
relations including relevant patient and stakeholder 
representatives.1 Findings from this patient and stake-
holder study will first and foremost be disseminated in 
articles published in peer- reviewed journals, as well as 
at national and international conferences. In addition, 
study outcomes will be disseminated to audiences outside 
the academic community through public presentations 
and popular science contributions in, for example, social 
media or in the press. The overall research programme 
will also organise annual RiH research seminars for 
academic partners, empirical partners and stakeholders. 
Annual RiH patient/stakeholder seminars will contribute 
to the creation of collaborative learning arenas involving 
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relevant stakeholders in the Norwegian healthcare system 
and RiH researchers, to enable translation of research 
evidence into interventions for stakeholder use.
Contributors VG and KA developed the initial idea for the study protocol. VG is the 
principal investigator of the PSI work package and drafted the original manuscript 
and contributed to manuscript revisions. KA and SW contributed substantial 
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